Best Practice for Newly Diagnosed Myeloma Patients Eligible for Transplant: How Can We Optimize Therapy?
Ben Derman on X: "CASSIOPEIA MRD analysis: Take a look at the top two PFS curves for Dara-VTd vs. VTd among MRD-negative patients. Doesn't seem like sustained MRD-negativity behaves the same? For
![Frontiers | Daratumumab for the Management of Newly Diagnosed and Relapsed/Refractory Multiple Myeloma: Current and Emerging Treatments Frontiers | Daratumumab for the Management of Newly Diagnosed and Relapsed/Refractory Multiple Myeloma: Current and Emerging Treatments](https://www.frontiersin.org/files/Articles/624661/fonc-10-624661-HTML/image_m/fonc-10-624661-g001.jpg)
Frontiers | Daratumumab for the Management of Newly Diagnosed and Relapsed/Refractory Multiple Myeloma: Current and Emerging Treatments
Ben Derman on X: "CASSIOPEIA MRD analysis: Take a look at the top two PFS curves for Dara-VTd vs. VTd among MRD-negative patients. Doesn't seem like sustained MRD-negativity behaves the same? For
![Multiple Myeloma Hub on X: "CONGRESS | #COMy20 | MM Hub SC member Philippe Moreau, @UnivNantes, discussed novel induction regimens to optimize outcomes to transplant. The benefit of KRd, Dara-VTd and Dara-RVd Multiple Myeloma Hub on X: "CONGRESS | #COMy20 | MM Hub SC member Philippe Moreau, @UnivNantes, discussed novel induction regimens to optimize outcomes to transplant. The benefit of KRd, Dara-VTd and Dara-RVd](https://pbs.twimg.com/media/EYDIZ94XsAA1rz2.png)
Multiple Myeloma Hub on X: "CONGRESS | #COMy20 | MM Hub SC member Philippe Moreau, @UnivNantes, discussed novel induction regimens to optimize outcomes to transplant. The benefit of KRd, Dara-VTd and Dara-RVd
Indications & Dosing | DARZALEX® (daratumumab) & DARZALEX FASPRO® (daratumumab and hyaluronidase-fihj) HCP
![Multiple Myeloma Hub on X: "#COMy22 | Cons continued... > Improvement in PFS over VRD alone even in pts achieving MRD negativity > Deepened response when using Dara-VTd plus ASCT vs Dara-VTd > Multiple Myeloma Hub on X: "#COMy22 | Cons continued... > Improvement in PFS over VRD alone even in pts achieving MRD negativity > Deepened response when using Dara-VTd plus ASCT vs Dara-VTd >](https://pbs.twimg.com/media/FStXpJyXEAAkWMc.jpg:large)
Multiple Myeloma Hub on X: "#COMy22 | Cons continued... > Improvement in PFS over VRD alone even in pts achieving MRD negativity > Deepened response when using Dara-VTd plus ASCT vs Dara-VTd >
![PDF) Evaluating Daratumumab in the Treatment of Multiple Myeloma: Safety, Efficacy and Place in Therapy PDF) Evaluating Daratumumab in the Treatment of Multiple Myeloma: Safety, Efficacy and Place in Therapy](https://www.researchgate.net/publication/343870342/figure/tbl2/AS:934129264758786@1599725180539/Pilot-Clinical-Trials-Evaluating-Daratumumab-in-Transplant-Eligible-Patients-with-NDMM_Q320.jpg)
PDF) Evaluating Daratumumab in the Treatment of Multiple Myeloma: Safety, Efficacy and Place in Therapy
![Cancers | Free Full-Text | Multiple Myeloma: An Overview of the Current and Novel Therapeutic Approaches in 2020 Cancers | Free Full-Text | Multiple Myeloma: An Overview of the Current and Novel Therapeutic Approaches in 2020](https://www.mdpi.com/cancers/cancers-12-02885/article_deploy/html/images/cancers-12-02885-g001.png)
Cancers | Free Full-Text | Multiple Myeloma: An Overview of the Current and Novel Therapeutic Approaches in 2020
![Frontiers | Safety of Rapid Daratumumab Infusion: A Retrospective, Multicenter, Real-Life Analysis on 134 Patients With Multiple Myeloma Frontiers | Safety of Rapid Daratumumab Infusion: A Retrospective, Multicenter, Real-Life Analysis on 134 Patients With Multiple Myeloma](https://www.frontiersin.org/files/Articles/851864/fonc-12-851864-HTML-r1/image_m/fonc-12-851864-t001.jpg)
Frontiers | Safety of Rapid Daratumumab Infusion: A Retrospective, Multicenter, Real-Life Analysis on 134 Patients With Multiple Myeloma
Suggested treatment options for newly diagnosed multiple myeloma (MM)... | Download Scientific Diagram
![Multiple Myeloma Hub on X: "#ASCO21 | Patients treated with dara+VTd/dara achieved higher responses and MRD negativity rates. 📢Share your experience with dara+VTd! How might the CASSIOPEIA results impact other trials exploring Multiple Myeloma Hub on X: "#ASCO21 | Patients treated with dara+VTd/dara achieved higher responses and MRD negativity rates. 📢Share your experience with dara+VTd! How might the CASSIOPEIA results impact other trials exploring](https://pbs.twimg.com/media/E3XpOnWWUAEd7SW.jpg:large)
Multiple Myeloma Hub on X: "#ASCO21 | Patients treated with dara+VTd/dara achieved higher responses and MRD negativity rates. 📢Share your experience with dara+VTd! How might the CASSIOPEIA results impact other trials exploring
![Daratumumab maintenance after treatment with VTd w/DARA and ASCT in pts with NDMM: CASSIOPEIA Part 2 Daratumumab maintenance after treatment with VTd w/DARA and ASCT in pts with NDMM: CASSIOPEIA Part 2](https://i.ytimg.com/vi/yJ5FIfU7k2o/maxresdefault.jpg)